Mersana Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Mersana Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2015 to 2023.
  • Mersana Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.19M, a 45.9% decline year-over-year.
  • Mersana Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $7.05M, a 54.5% increase year-over-year.
  • Mersana Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $8M.
  • Mersana Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$445K, a 63% increase from 2021.
  • Mersana Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.2M, a 1949% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $8M +$8.45M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$445K +$757K +63% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$1.2M -$1.27M -1949% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $65K -$1.93M -96.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $1.99M +$594K +42.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $1.4M +$488K +53.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $910K +$789K +652% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $121K +$208K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-08
2015 -$87K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.